Bristol-Myers Squibb | BMY - Market Capitalization

Stock Price
56.95
Daily Change
-0.43 -0.75%
Monthly
-4.01%
Yearly
19.72%
Q2 Forecast
57.01

Bristol-Myers Squibb reported $116.26B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Abbott USD 178.41B 39.46B Mar/2026
ALKERMES USD 5.53B 909M May/2026
Amgen USD 189.89B 13.64B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Coherus Biosciences USD 172M 19M Dec/2025
Drreddys Laboratories INR 11.69B 50M Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 232.75B 75B May/2026
Novo Nordisk A/S DKK 1.45T 86.62B Dec/2025
Perrigo USD 1.92B 1.04B Dec/2025
Pfizer USD 148.08B 6.51B May/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.97B 105M Dec/2025
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
United Therapeutics USD 20.98B 2.02B Dec/2025
Zoetis USD 55.45B 9.4B Dec/2025